Next Article in Journal
Classifying and Monitoring Primary Progressive Aphasia in the Greek Population: A “Mini Linguistic State Examination (MLSE)” Tool
Previous Article in Journal
Clinical, Laboratory and Instrumental Characteristics of Myocardial Infarction in Young Patients Depending on the Prevalence of Coronary Atherosclerosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 61
Issue 11
10.3390/medicina61111997
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Medicina 2025, 61(4), 638.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638

by
Ziya Kalkan
1,*,
Senar Ebinc
2,
Murat Arcagok
3,
Ahmet Bilici
4,
Ozcan Yildiz
4,
Saadettin Kilickap
5,
Deniz Can Guven
6,
Ali Murat Tatli
7,
Ahmet Taner Sumbul
8,
Nil Molinas Mandel
9,
Akin Ozturk
10,
Murat Bardakci
11,
Serdar Karakaya
12 and
Muhammet Ali Kaplan
3
1
Department of Medical Oncology, Mardin Training and Research Hospital, Mardin 47100, Türkiye
2
Department of Medical Oncology, Van Yuzuncu Yil University Faculty of Medicine, Van 65100, Türkiye
3
Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir 21100, Türkiye
4
Department of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34000, Türkiye
5
Department of Medical Oncology, Istinye University Faculty of Medicine, Istanbul 34000, Türkiye
6
Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06000, Türkiye
7
Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya 07000, Türkiye
8
Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana 01100, Türkiye
9
Department of Medical Oncology, American Hospital, Istanbul 34000, Türkiye
10
Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul 34000, Türkiye
11
Department of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir 21100, Türkiye
12
Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara 06000, Türkiye
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Medicina 2025, 61(11), 1997; https://doi.org/10.3390/medicina61111997
Submission received: 7 October 2025 / Revised: 9 October 2025 / Accepted: 27 October 2025 / Published: 7 November 2025
Browse Figure
Versions Notes

Error in Figure

In the original publication, there was a mistake in Figure 2 as published [1]. Only the Kaplan–Meier curve needs to be updated because it is currently identical to the one in Figure 1. The corrected Figure 2 is as follows. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Kalkan, Z.; Ebinc, S.; Arcagok, M.; Bilici, A.; Yildiz, O.; Kilickap, S.; Guven, D.C.; Tatli, A.M.; Sumbul, A.T.; Mandel, N.M.; et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638. [Google Scholar] [CrossRef] [PubMed]
Medicina 61 01997 g002
Figure 2. PFS3 Kaplan–Meier survival analysis according to treatment regimens.
Figure 2. PFS3 Kaplan–Meier survival analysis according to treatment regimens.
Medicina 61 01997 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kalkan, Z.; Ebinc, S.; Arcagok, M.; Bilici, A.; Yildiz, O.; Kilickap, S.; Guven, D.C.; Tatli, A.M.; Sumbul, A.T.; Mandel, N.M.; et al. Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638. Medicina 2025, 61, 1997. https://doi.org/10.3390/medicina61111997

AMA Style

Kalkan Z, Ebinc S, Arcagok M, Bilici A, Yildiz O, Kilickap S, Guven DC, Tatli AM, Sumbul AT, Mandel NM, et al. Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638. Medicina. 2025; 61(11):1997. https://doi.org/10.3390/medicina61111997

Chicago/Turabian Style

Kalkan, Ziya, Senar Ebinc, Murat Arcagok, Ahmet Bilici, Ozcan Yildiz, Saadettin Kilickap, Deniz Can Guven, Ali Murat Tatli, Ahmet Taner Sumbul, Nil Molinas Mandel, and et al. 2025. "Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638" Medicina 61, no. 11: 1997. https://doi.org/10.3390/medicina61111997

APA Style

Kalkan, Z., Ebinc, S., Arcagok, M., Bilici, A., Yildiz, O., Kilickap, S., Guven, D. C., Tatli, A. M., Sumbul, A. T., Mandel, N. M., Ozturk, A., Bardakci, M., Karakaya, S., & Kaplan, M. A. (2025). Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638. Medicina, 61(11), 1997. https://doi.org/10.3390/medicina61111997

Article Metrics

Back to TopTop